Cargando…
Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Using Murine Models to Understand Human Pathology
Respiratory syncytial virus (RSV) causes severe pathology of the lower respiratory tract in infants, immunocompromised people, and elderly. Despite decades of research, there is no licensed vaccine against RSV, and many therapeutic drugs are still under development. Detailed understanding of molecul...
Autores principales: | Shilovskiy, Igor P., Yumashev, Kirill V., Nikolsky, Alexandr A., Vishnyakova, Liudmila I., Khaitov, Musa R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957450/ https://www.ncbi.nlm.nih.gov/pubmed/33838630 http://dx.doi.org/10.1134/S0006297921030068 |
Ejemplares similares
-
The TLR4 Agonist Immunomax Affects the Phenotype of Mouse Lung Macrophages during Respiratory Syncytial Virus Infection
por: Nikonova, A. A., et al.
Publicado: (2018) -
Antiviral Therapy of COVID-19
por: Gudima, Georgii, et al.
Publicado: (2023) -
The Cellular and Viral circRNAome Induced by Respiratory Syncytial Virus Infection
por: Yao, Wenxia, et al.
Publicado: (2021) -
Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
por: Altamirano-Lagos, María José, et al.
Publicado: (2019) -
Bioenergetics of murine lungs infected with respiratory syncytial virus
por: Alsuwaidi, Ahmed R, et al.
Publicado: (2013)